UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 274

Sortiert nach

Incidence and characteristics of post-COVID-19 parkinsonism and dyskinesia related to COVID-19 vaccines

Neurologia i neurochirurgia polska, 2023-01, Vol.57 (1), p.53-62

2023

Link zum Volltext

Verfügbarkeit prüfen

Fibrodysplasia ossificans progressiva as a form of pseudodystonia

Parkinsonism & related disorders, 2020-08, Vol.77, p.180-181

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of Botulinum toxin type A preparations in cerebral palsy - an evidence-based review

Neurologia i neurochirurgia polska, 2021-01, Vol.55 (2), p.158-164

2021

Link zum Volltext

Verfügbarkeit prüfen

Botulinum Toxin for the Management of Cervical Dystonia and Why Patients Discontinue Treatment: How Can We Do Better?

Toxicon (Oxford), 2024-01, Vol.237, p.107491, Article 107491

Slawek, Jaroslaw

2024

Link zum Volltext

Verfügbarkeit prüfen

Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review

Journal of Neural Transmission, 2023-11, Vol.130 (11), p.1359-1377

2023

Link zum Volltext

Verfügbarkeit prüfen

Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome

Neurologia i neurochirurgia polska, 2021-06, Vol.55 (3), p.310-313

2021

Link zum Volltext

Verfügbarkeit prüfen

Does Ultrasound Guidance Improve the Effectiveness of Neurotoxin Injections in Patients with Cervical Dystonia? (A Prospective, Partially-Blinded, Clinical Study)

Toxins, 2022-09, Vol.14 (10), p.674

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential diagnosis of Huntington’s disease− neurological aspects of NKX2-1-related disorders

Journal of Neural Transmission, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

Cannabis in Parkinson's Disease - the patient's perspective versus clinical trials: a systematic literature review

Neurologia i neurochirurgia polska, 2022-01, Vol.56 (1), p.21-27

2022

Link zum Volltext

Verfügbarkeit prüfen

Hyperkinetic movement disorders following SARS-CoV-2 infection and vaccination - an update

Neurologia i neurochirurgia polska, 2023-01, Vol.57 (1), p.63-76

2023

Link zum Volltext

Verfügbarkeit prüfen

Post‐COVID‐19 Myoclonus‐Ataxia Syndrome—Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?

Movement disorders clinical practice (Hoboken, N.J.), 2023-04, Vol.10 (4), p.724-725

2023

Link zum Volltext

Verfügbarkeit prüfen

The prevalence of the restless legs Syndrome/Willis-Ekbom disease among teenagers, its clinical characteristics and impact on everyday functioning

Sleep medicine, 2022-01, Vol.89, p.48-54

2022

Link zum Volltext

Verfügbarkeit prüfen

Botulinum toxin A brands are not the same medications. A comment on Hary et al

European journal of pain, 2022-07, Vol.26 (6), p.1396-1396

Slawek, Jaroslaw

2022

Link zum Volltext

Verfügbarkeit prüfen

An updated diagnostic approach to subtype definition of vascular parkinsonism – Recommendations from an expert working group

Parkinsonism & related disorders, 2018-04, Vol.49, p.9-16

2018

Link zum Volltext

Verfügbarkeit prüfen

Botulinum neurotoxin in cervical dystonia revisited - recent advances and unanswered questions

Neurologia i neurochirurgia polska, 2021-01, Vol.55 (2), p.125-132

2021

Link zum Volltext

Verfügbarkeit prüfen

Acute/subacutae demyelinating polyneuropathy in Parkinson's Disease patients on levodopa-carbidopa intestinal gel therapy: systematic review with new case report

Neurologia i neurochirurgia polska, 2023-01, Vol.57 (2), p.169-176

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and predictors of post-stroke spasticity and its impact on daily living and quality of life

Neurologia i neurochirurgia polska, 2019-01, Vol.53 (6), p.449-457

2019

Link zum Volltext

Verfügbarkeit prüfen

First report on spinocerebellar ataxia type 3 (Machado–Joseph disease) in Poland

Parkinsonism & related disorders, 2022-12, Vol.105, p.39-42

2022

Link zum Volltext

Verfügbarkeit prüfen

Response to 'Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out'

Neurologia i neurochirurgia polska, 2023-01, Vol.57 (4), p.403-404

2023

Link zum Volltext

Verfügbarkeit prüfen

Botulinum neurotoxin in neurological practice - a leading topic in neurology

Neurologia i neurochirurgia polska, 2021-01, Vol.55 (2), p.120-124

2021

Link zum Volltext

Verfügbarkeit prüfen

New Insight into 2-Methoxyestradiol- a Possible Physiological Link between Neurodegeneration and Cancer Cell Death

Current medicinal chemistry, 2016-05, Vol.23 (15), p.1513

2016

Link zum Volltext

Verfügbarkeit prüfen

DCTN1 -related neurodegeneration: Perry syndrome and beyond

Parkinsonism & related disorders, 2017-08, Vol.41, p.14-24

2017

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Subthalamic Deep Brain Stimulation on Restless Legs Syndrome in Parkinson's Disease

Neuromodulation (Malden, Mass.), 2022-08, Vol.25 (6), p.904-910

2022

Link zum Volltext

Verfügbarkeit prüfen

Restless legs syndrome in adolescents

Brain & development (Tokyo. 1979), 2018-02, Vol.40 (2), p.163-163

2018

Link zum Volltext

Verfügbarkeit prüfen

L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome

Parkinsonism & related disorders, 2022-07, Vol.100, p.19-23

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(264)
Mit Volltextzugriff
(241)

Publikationsform

Sprache

Englisch
(241)
Polnisch
(41)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Incidence and characteristics of post-COVID-19 parkinsonism and dyskinesia related to COVID-19 vaccines

Fibrodysplasia ossificans progressiva as a form of pseudodystonia

Safety and efficacy of Botulinum toxin type A preparations in cerebral palsy - an evidence-based review

Botulinum Toxin for the Management of Cervical Dystonia and Why Patients Discontinue Treatment: How Can We Do Better?

Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review

Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome

Does Ultrasound Guidance Improve the Effectiveness of Neurotoxin Injections in Patients with Cervical Dystonia? (A Prospective, Partially-Blinded, Clinical Study)

Differential diagnosis of Huntington’s disease− neurological aspects of NKX2-1-related disorders

Cannabis in Parkinson's Disease - the patient's perspective versus clinical trials: a systematic literature review

Hyperkinetic movement disorders following SARS-CoV-2 infection and vaccination - an update

Post‐COVID‐19 Myoclonus‐Ataxia Syndrome—Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?

The prevalence of the restless legs Syndrome/Willis-Ekbom disease among teenagers, its clinical characteristics and impact on everyday functioning

Botulinum toxin A brands are not the same medications. A comment on Hary et al

An updated diagnostic approach to subtype definition of vascular parkinsonism – Recommendations from an expert working group

Botulinum neurotoxin in cervical dystonia revisited - recent advances and unanswered questions

Acute/subacutae demyelinating polyneuropathy in Parkinson's Disease patients on levodopa-carbidopa intestinal gel therapy: systematic review with new case report

Prevalence and predictors of post-stroke spasticity and its impact on daily living and quality of life

First report on spinocerebellar ataxia type 3 (Machado–Joseph disease) in Poland

Response to 'Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out'

Botulinum neurotoxin in neurological practice - a leading topic in neurology

New Insight into 2-Methoxyestradiol- a Possible Physiological Link between Neurodegeneration and Cancer Cell Death

DCTN1 -related neurodegeneration: Perry syndrome and beyond

The Impact of Subthalamic Deep Brain Stimulation on Restless Legs Syndrome in Parkinson's Disease

Restless legs syndrome in adolescents

L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome

Suchergebnisse filtern